KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Long-Term Investments (2018 - 2025)

BioNTech SE's Long-Term Investments history spans 7 years, with the latest figure at $87.8 million for Q3 2025.

  • On a quarterly basis, Long-Term Investments changed N/A to $87.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $87.8 million, a N/A change, with the full-year FY2023 number at $1.2 billion, up 561.12% from a year prior.
  • Long-Term Investments hit $87.8 million in Q3 2025 for BioNTech SE, down from $101.9 million in the prior quarter.
  • Over the last five years, Long-Term Investments for BNTX hit a ceiling of $1.2 billion in Q4 2023 and a floor of $24.4 million in Q4 2021.
  • Historically, Long-Term Investments has averaged $220.0 million across 5 years, with a median of $101.9 million in 2025.
  • Biggest five-year swings in Long-Term Investments: soared 637.76% in 2022 and later crashed 73.49% in 2025.
  • Tracing BNTX's Long-Term Investments over 5 years: stood at $24.4 million in 2021, then soared by 637.76% to $179.8 million in 2022, then soared by 561.12% to $1.2 billion in 2023, then crashed by 79.77% to $240.4 million in 2024, then plummeted by 63.48% to $87.8 million in 2025.
  • Business Quant data shows Long-Term Investments for BNTX at $87.8 million in Q3 2025, $101.9 million in Q2 2025, and $63.7 million in Q1 2025.